Inventor · Frankfurt am Main, DE

Christian Buning

25Patents
3h-index
27Co-inventors
59Inventor score

Filing activity: Jul 26, 2004 → Feb 20, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US7094800B2 Cyanopyrrolidides, process for their preparation and their use as medicaments Chemistry; Metallurgy 17 Expired
US7008957B2 Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments Chemistry; Metallurgy 16 Expired
US8003668B2 Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders Human Necessities 4 Active
US7569700B2 Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments Human Necessities 2 Active
US8138207B2 Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions Human Necessities 2 Active
US7888343B2 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase Human Necessities 1 Active
US9120783B2 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 1 Active
US8163774B2 Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments Chemistry; Metallurgy 1 Active
US9751858B2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 1 Active
US9353068B2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 1 Active
US8664257B2 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 1 Active
US10392366B2 Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Chemistry; Metallurgy 1 Active
US8236810B2 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV Chemistry; Metallurgy 0 Active
US9758520B2 Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Chemistry; Metallurgy 0 Active
US7879864B2 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes Human Necessities 0 Active
US9908868B2 Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Chemistry; Metallurgy 0 Active
US9896434B2 Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Chemistry; Metallurgy 0 Active
US7795445B2 Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use Human Necessities 0 Active
US9174952B2 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active
US8962671B2 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active
US9029559B2 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active
US7838528B2 Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use Human Necessities 0 Active
US9199947B2 Biaryl-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active
US9150526B2 Biaryl-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active
US8669370B2 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.